Feb 12 (Reuters) - Medicenna Therapeutics Corp:
* MEDICENNA THERAPEUTICS CORP - QTRLY LOSS PER SHARE $0.09
* MEDICENNA THERAPEUTICS CORP - ENDED QUARTER WITH TOTAL AVAILABLE FUNDING OF APPROXIMATELY $14.5 MILLION, ENOUGH TO FUND OPERATIONS INTO Q1 2019 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.